Pipeline
Despite significant advances in endocrinology, there are still large unmet needs for effective and safe treatments. We are building, expanding and rapidly advancing a pipeline of innovative peptides.
Therapeutic peptides are particularly well suited as drugs for endocrine diseases because many hormones are peptides or proteins.
Our portfolio currently includes:
- Eneboparatide, a potential treatment for hypoparathyroidism
- AZP-3813, a potential treatment for acromegaly
With our team’s established expertise in therapeutic peptides, we aim to further expand and rapidly advance our pipeline of promising innovative peptides through global approval.